Fiduciary Management Upped Penske Automotive (PAG) Stake By $18.41 Million; Bluebird Bio (BLUE) SI Increased By 10.72%

January 17, 2018 - By Migdalia James

Bluebird Bio Incorporated (NASDAQ:BLUE) had an increase of 10.72% in short interest. BLUE’s SI was 4.16M shares in January as released by FINRA. Its up 10.72% from 3.76M shares previously. With 491,700 avg volume, 9 days are for Bluebird Bio Incorporated (NASDAQ:BLUE)’s short sellers to cover BLUE’s short positions. The SI to Bluebird Bio Incorporated’s float is 10.28%. The stock increased 8.72% or $14.25 during the last trading session, reaching $177.6. About 1.60 million shares traded or 78.86% up from the average. bluebird bio, Inc. (NASDAQ:BLUE) has risen 112.34% since January 17, 2017 and is uptrending. It has outperformed by 95.64% the S&P500.

Fiduciary Management Inc increased Penske Automotive (PAG) stake by 26.88% reported in 2017Q3 SEC filing. Fiduciary Management Inc acquired 391,808 shares as Penske Automotive (PAG)’s stock declined 16.17%. The Fiduciary Management Inc holds 1.85 million shares with $87.98 million value, up from 1.46M last quarter. Penske Automotive now has $4.50B valuation. The stock increased 0.48% or $0.25 during the last trading session, reaching $52.5. About 389,687 shares traded. Penske Automotive Group, Inc. (NYSE:PAG) has risen 20.45% since January 17, 2017 and is uptrending. It has outperformed by 3.75% the S&P500.

Among 25 analysts covering bluebird bio (NASDAQ:BLUE), 15 have Buy rating, 2 Sell and 8 Hold. Therefore 60% are positive. bluebird bio had 79 analyst reports since August 11, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Wells Fargo on Friday, December 4. The stock of bluebird bio, Inc. (NASDAQ:BLUE) has “Buy” rating given on Monday, December 11 by SunTrust. On Thursday, December 3 the stock rating was initiated by TH Capital with “Buy”. The rating was maintained by BTIG Research with “Buy” on Wednesday, May 31. The rating was maintained by Wedbush on Thursday, November 2 with “Buy”. Maxim Group maintained bluebird bio, Inc. (NASDAQ:BLUE) on Thursday, November 30 with “Buy” rating. The firm has “Buy” rating by Cowen & Co given on Friday, June 23. The stock has “Buy” rating by Roth Capital on Thursday, September 22. The company was maintained on Thursday, August 3 by BTIG Research. Jefferies initiated it with “Buy” rating and $108 target in Friday, October 23 report.

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. The company has market cap of $8.71 billion. The Company’s product candidates include Lenti-D that is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder; and LentiGlobin, which is in four clinical studies for the treatment of transfusion-dependent beta-thalassemia, and severe sickle cell disease. It currently has negative earnings. The companyÂ’s lead product candidate is bb2121, a chimeric antigen receptor T cell product candidate that is in Phase I trial for the treatment of relapsed/refractory multiple myeloma. bluebird bio, Inc. has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology; Kite Pharma, Inc. to develop and commercialize second generation T cell receptor product candidates against an antigen related to certain cancers associated with the human papilloma virus; and Medigene AG for the research and development of TCR product candidates directed against approximately four antigens for the treatment of cancer indications.

Investors sentiment increased to 1.79 in 2017 Q3. Its up 0.11, from 1.68 in 2017Q2. It is positive, as 35 investors sold bluebird bio, Inc. shares while 42 reduced holdings. 45 funds opened positions while 93 raised stakes. 49.05 million shares or 2.37% more from 47.91 million shares in 2017Q2 were reported. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% in bluebird bio, Inc. (NASDAQ:BLUE). Sivik Healthcare Limited Liability Corporation invested 0.82% of its portfolio in bluebird bio, Inc. (NASDAQ:BLUE). Metropolitan Life Insurance Ny accumulated 30,518 shares. Research Glob Invsts has invested 0.23% in bluebird bio, Inc. (NASDAQ:BLUE). Panagora Asset Incorporated invested in 2,227 shares. Moreover, California State Teachers Retirement System has 0.02% invested in bluebird bio, Inc. (NASDAQ:BLUE) for 73,150 shares. Aperio Limited Liability Co owns 0% invested in bluebird bio, Inc. (NASDAQ:BLUE) for 5,299 shares. Great West Life Assurance Can reported 5,531 shares or 0% of all its holdings. Highlander Mngmt Ltd Liability Company reported 1,500 shares. Orbimed Advsr Limited Com holds 481,946 shares or 0.63% of its portfolio. Winslow Evans Crocker stated it has 3,800 shares. Armistice Cap Limited Liability Corporation reported 38,000 shares stake. Marshall Wace Ltd Liability Partnership holds 0.02% or 3,516 shares. Goldman Sachs Grp invested in 279,076 shares. The United Kingdom-based Pictet Asset has invested 0.04% in bluebird bio, Inc. (NASDAQ:BLUE).

Among 7 analysts covering Penske Automotive Group (NYSE:PAG), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Penske Automotive Group had 12 analyst reports since October 14, 2015 according to SRatingsIntel. The rating was maintained by KeyBanc Capital Markets on Monday, November 13 with “Hold”. The stock of Penske Automotive Group, Inc. (NYSE:PAG) has “Buy” rating given on Friday, April 28 by Gabelli. The rating was downgraded by KeyBanc Capital Markets to “Sector Perform” on Tuesday, June 28. The firm has “Positive” rating by Susquehanna given on Thursday, February 2. KeyBanc Capital Markets maintained Penske Automotive Group, Inc. (NYSE:PAG) on Thursday, August 31 with “Hold” rating. The firm has “Hold” rating given on Thursday, September 15 by Gabelli. The firm has “Buy” rating given on Thursday, September 28 by Northcoast. As per Tuesday, August 9, the company rating was initiated by Seaport Global. On Tuesday, October 3 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. Evercore downgraded Penske Automotive Group, Inc. (NYSE:PAG) on Thursday, October 13 to “Sell” rating.

Fiduciary Management Inc decreased Robert Half Int’l. Inc. (NYSE:RHI) stake by 23,885 shares to 2.18 million valued at $109.67M in 2017Q3. It also reduced Potash Corp. (NYSE:POT) stake by 484,680 shares and now owns 36.86M shares. Cable One Inc. was reduced too.

Since August 9, 2017, it had 2 insider purchases, and 2 insider sales for $49.79 million activity. 1.10 million Penske Automotive Group, Inc. (NYSE:PAG) shares with value of $50.00M were sold by MITSUI & CO LTD. PENSKE ROGER S also bought $50.00 million worth of Penske Automotive Group, Inc. (NYSE:PAG) on Friday, October 20. 5,000 shares were sold by Denker Claude H III, worth $206,345. 1.10 million shares valued at $50.00M were bought by PENSKE CORP on Friday, October 20.

Investors sentiment increased to 1.28 in Q3 2017. Its up 0.38, from 0.9 in 2017Q2. It improved, as 26 investors sold PAG shares while 55 reduced holdings. 42 funds opened positions while 62 raised stakes. 34.35 million shares or 3.33% more from 33.24 million shares in 2017Q2 were reported. Alpha Windward Limited Com holds 11,700 shares or 0.34% of its portfolio. Moreover, Manufacturers Life Ins The has 0% invested in Penske Automotive Group, Inc. (NYSE:PAG). Fiduciary Mgmt Wi reported 0.52% in Penske Automotive Group, Inc. (NYSE:PAG). Vantage Invest Advsr Llc stated it has 55 shares. Oppenheimer Asset stated it has 0% in Penske Automotive Group, Inc. (NYSE:PAG). Schwab Charles Investment Management has invested 0.01% of its portfolio in Penske Automotive Group, Inc. (NYSE:PAG). Moreover, Bartlett Communication Ltd has 0% invested in Penske Automotive Group, Inc. (NYSE:PAG). Pacad Investment Ltd owns 2,700 shares or 0.03% of their US portfolio. North Star invested in 150 shares. Vanguard Grp accumulated 2.80M shares or 0.01% of the stock. Ubs Asset Mgmt Americas has invested 0% in Penske Automotive Group, Inc. (NYSE:PAG). Amalgamated Bankshares has invested 0.01% of its portfolio in Penske Automotive Group, Inc. (NYSE:PAG). Brinker Inc has 0.08% invested in Penske Automotive Group, Inc. (NYSE:PAG) for 39,111 shares. Comerica Commercial Bank owns 22,320 shares for 0.01% of their portfolio. Deprince Race And Zollo invested in 0.4% or 375,074 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: